Semalytix, a Bielefeld, Germany-based startup that offers pharmaceutical companies an AI-powered data tool to better understand real-world patient experiences, has raised €4.3 million in Series A funding. Leading the round is venture capital firm btov Partners, with participation from existing investor Fly Ventures and several unnamed angels. Semalytix will use the injection of cash to […] …Continue Reading